feeds.newsfilecorp.com · 29 jul

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 29, 2026) - Kahn Swick and Foti, LLC ("KSF")

newsfilecorp.com · 29 jul

ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ADMA

New York, New York--(Newsfile Corp. - July 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024 and March 25, 2026, both dates inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased ADMA Biologics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

gurufocus.com · 29 jul

ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- HBSS

ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- HBSS

prnewswire.com · 29 jul

ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- HBSS

SAN FRANCISCO, July 29, 2026 /PRNewswire/ -- Hagens Berman alerts investors in ADMA Biologics, Inc. (NASDAQ: ADMA) that a securities fraud class action lawsuit has been filed. The lawsuit focuses on alleged misrepresentations concerning the company's financial condition, revenue recognition, inventory distribution, and business practices.

zacks.com · 29 jul

Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

prnewswire.com · 29 jul

Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 10, 2026 - ADMA

Pension funds and asset managers holding ADMA Biologics positions during the Class Period face potential fiduciary exposure as alleged channel stuffing scheme inflated ASCENIV revenues from $92.6 million to $362.5 million over two years. NEW YORK, July 29, 2026 /PRNewswire/ -- Institutional investors holding positions in ADMA Biologics, Inc. (NASDAQ: ADMA) during the period August 9, 2024 through March 25, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action.

newsfilecorp.com · 29 jul

ADMA BIOLOGICS, INC. (ADMA) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action

Philadelphia, Pennsylvania--(Newsfile Corp. - July 29, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA) ("ADMA" or the "Company") on behalf of investors who purchased or acquired ADMA common stock during the period from August 9, 2024 through March 25, 2026 (the "Class Period"). Investor Deadline: Investors who purchased or acquired ADMA securities during the Class Period may, no later than August 10, 2026, seek to be appointed as a lead plaintiff representative of the class.

globenewswire.com · 29 jul

ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 10, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA) of the  August 10, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The ADMA Class Action Lawsuit : Do you, or did you, own shares of ADMA Biologics, Inc. (NASDAQ: ADMA)?